Scientists test new Drug's ability to calm artificial lung inflammation
Knowledge-focused
Completed
This early-stage study tested whether an oral drug called EP395 could reduce markers of lung inflammation in healthy adults. Researchers gave 40 participants either EP395 or a placebo for 21 days, then used a safe, inhaled substance to temporarily cause mild airway inflammation t…
Phase: PHASE1 • Sponsor: EpiEndo Pharmaceuticals • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:40 UTC